Trump’s MFN Drug Pricing Policy Is Reshaping Pharmaceutical Markets
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
Mariann completed her Master of Science degree at the Department of Biosciences of the University of Helsinki in 2007, majoring in Physiology and minoring in Biochemistry. She finished her PhD in June 2016 with research concentrating on diabetes and the long-term complications related to the disease.
We want to warmly welcome Mariann to our growing team!

The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
Medaffcon brings to the health technology market the kind of effectiveness and cost-conscious thinking well established in the pharmaceutical industry.
Medaffcon's scrum model provides an agile way of working, enabling seamless knowledge sharing between teams and keeping projects on track.